English Korean
Aquavit Pharmaceuticals

“We are pioneering personalized healthcare for patients through modern delivery systems.

Our mission is to discover, develop and commercialize innovative products that enable people to live to their greatest potential.”

Sobin Chang, CEO

Corporate Updates

Piracy Alert   RedFlag

Aquavit Pharmaceuticals Adds New Patent To Its High-Tech Medical Portfolio

Aquavit’s iMicrotox™ (IMX-001) Study Receives IRB Approval

Science Personalized. Healthcare Modernized.

Aquavit Pharmaceuticals, Inc. is a high-tech pharmaceutical company. We provide a comprehensive range of innovative pharmaceutical, biotech and medical device technologies. We are developing the first of its kind, smart desktop compounding technology (PITO-001/QVT series) with AI integration and a big data platform (MAV series).

AQT technology (AQUAGOLD® fine touch ) is a precursor to our comprehensive personalized delivery technology platform. Our breadth of intellectual property covers the first in the world desktop compounding technology, personalized injectable formulations, microchannel mesotherapy, repeated motion delivery using microchannels, and any related combination therapy using microchannel technology.

We are conducting an in-depth research on microchannel application of neurotoxins (IMT-121). The success of this development will bring the first FDA approved microchannel delivery of neurotoxins for the peri-orbital region in the US.